Dr. Ramadoss is currently a Research Scientist at Stanford University in the laboratory of Dr. William Robinson. Her research focuses on mapping the transcriptional landscapes and B cell receptor repertoires of Borrelia burgdorferi antigen-specific B cells in individuals that suffer from Post-treatment Lyme Disease Syndrome (PTLDS), in an effort to understand why some people return to health after antibiotic treatment post-Borrelia infection, while others do not.
Dr. Ramadoss earned a MSc in Chemical Biology from University of Leeds and a PhD in Biochemistry, Molecular Biology and Microbiology from the Pennsylvania State University. She then went on to complete her postdoctoral studies at both the California Institute for Biomedical Research (Calibr at Scripps Research), and Stanford University. Her innovative therapeutic project was selected for a 2021 Emerging Leader Award, a $100,000 grant.